test bank for
pharmacology and the nursing process 9th
edition by lilley
(covers chapters 1-58 with 100% verified
answer)
,table of contents
chapter 01: the nursing process and drug therapy .............................................. 5
chapter 02: pharmacologic principles .................................................................. 9
chapter 03: lifespan considerations ................................................................... 17
chapter 04: cultural, legal, and ethical considerations ...................................... 24
chapter 05: medication errors: preventing and responding ............................... 30
chapter 06: patient education and drug therapy ............................................... 35
chapter 07: over-the-counter drugs and herbal and dietary supplements ......... 40
chapter 08: gene therapy and pharmacogenomics............................................ 45
chapter 09: photo atlas of drug administration ................................................. 50
chapter 10: analgesic drugs .............................................................................. 61
chapter 11: general and local anesthetics ......................................................... 69
chapter 12: central nervous system depressants and muscle relaxants ............. 73
chapter 13: central nervous system stimulants and related drugs ..................... 79
chapter 14: antiepileptic drugs ......................................................................... 84
chapter 15: antiparkinson drugs ....................................................................... 90
chapter 16: psychotherapeutic drugs ................................................................ 96
chapter 17: substance use disorder ................................................................. 104
chapter 18: adrenergic drugs .......................................................................... 110
chapter 19: adrenergic-blocking drugs ............................................................ 115
chapter 20: cholinergic drugs .......................................................................... 121
chapter 21: cholinergic-blocking drugs ............................................................ 127
chapter 22: antihypertensive drugs ................................................................. 133
chapter 23: antianginal drugs ......................................................................... 141
chapter 24: heart failure drugs........................................................................ 147
chapter 25: antidysrhythmic drugs .................................................................. 154
chapter 26: coagulation modifier drugs .......................................................... 160
chapter 27: antilipemic drugs.......................................................................... 167
,chapter 28: diuretic drugs ............................................................................... 173
chapter 29: fluids and electrolytes .................................................................. 180
chapter 30: pituitary drugs ............................................................................. 187
chapter 31: thyroid and antithyroid drugs....................................................... 191
chapter 32: antidiabetic drugs ........................................................................ 197
chapter 33: adrenal drugs ............................................................................... 207
chapter 34: women’s health drugs .................................................................. 212
chapter 35: men’s health drugs ....................................................................... 221
chapter 36: antihistamines, decongestants, antitussives, and expectorants .... 226
chapter 37: respiratory drugs .......................................................................... 232
chapter 38: antibiotics part 1 .......................................................................... 238
chapter 39: antibiotics part 2 .......................................................................... 246
chapter 40: antiviral drugs .............................................................................. 252
chapter 41: antitubercular drugs..................................................................... 258
chapter 42: antifungal drugs ........................................................................... 264
chapter 43: antimalarial, antiprotozoal, and anthelmintic drugs .................... 270
chapter 44: anti-inflammatory and antigout drugs ......................................... 275
chapter 45: antineoplastic drugs part 1: cancer overview and cell cycle-specific
drugs .............................................................................................................. 282
chapter 46: antineoplastic drugs part 2: cell cycle–nonspecific drugs and
miscellaneous drugs........................................................................................ 288
chapter 47: biologic response–modifying and antirheumatic drugs................. 294
chapter 48: immunosuppressant drugs ........................................................... 300
chapter 49: immunizing drugs ......................................................................... 306
chapter 50: acid-controlling drugs................................................................... 311
chapter 51: bowel disorder drugs .................................................................... 318
chapter 52: antiemetic and antinausea drugs ................................................. 327
chapter 53: vitamins and minerals .................................................................. 333
,chapter 54: anemia drugs ............................................................................... 339
chapter 55: nutritional supplements ............................................................... 347
chapter 56: dermatologic drugs ...................................................................... 353
chapter 57: ophthalmic drugs ......................................................................... 360
chapter 58: otic drugs ..................................................................................... 365
,chapter 01: the nursing process and drug therapy
lilley: pharmacology and the nursing process, 9th edition
multiple choice
1. the nurse is developing a human needs statement for a patient who has a new diagnosis of
heart failure. identification of human needs statements occur with which of these activities?
a. collection of patient data
b. administering interventions
c. deciding on patient outcomes
d. documenting the patient’s behavior
CORRECT ANSWER>>>a
identification of human needs occurs with the collection of patient data.
dif: cognitive level: understanding (comprehension) top: nursing process: human needs statement
msc: nclex: safe and effective care environment: management of care
2. the patient is to receive oral guaifenesin (mucinex) twice a day. today, the nurse was busy and
gave the medication 2 hours after the scheduled dose was due. what type of problem does this
represent?
a. “right time”
b. “right dose”
c. “right route”
d. “right medication”
CORRECT ANSWER>>>a
“right time” is correct because the medication was given more than 30 minutes after the scheduled dose
was due. “dose” is incorrect because the dose is not related to the time the medication administration is
scheduled. “route” is incorrect because the route is not affected. “medication” is incorrect because the
medication ordered will not change.
dif: cognitive level: applying (application) top: nursing process: implementation
msc: nclex: safe and effective care environment: safety and infection control
,3. the nurse has been monitoring the patient’s progress on a new drug regimen since the first dose
and documenting the patient’s therapeutic response to the medication. which phase of the nursing
process do these actions illustrate?
a. human needs statement
b. planning
c. implementation
d. evaluation
CORRECT ANSWER>>>d
monitoring the patient’s progress, including the patient’s response to the medication, is part of the
evaluation phase. planning, implementation, and human needs statement are not illustrated by this
example.
dif: cognitive level: understanding (comprehension) top: nursing process: evaluation
msc: nclex: safe and effective care environment: management of care
4. the nurse is assigned to a patient who is newly diagnosed with type 1 diabetes mellitus. which
statement best illustrates an outcome criterion for this patient?
a. the patient will follow instructions.
b. the patient will not experience complications.
c. the patient will adhere to the new insulin treatment regimen.
d. the patient will demonstrate correct blood glucose testing technique.
CORRECT ANSWER>>>d
“demonstrating correct blood glucose testing technique” is a specific and measurable outcome criterion.
“following instructions” and “not experiencing complications” are not specific criteria. “adhering to new
regimen” would be difficult to measure.
dif: cognitive level: applying (application) top: nursing process: planning
msc: nclex: safe and effective care environment: management of care
5. which activity best reflects the implementation phase of the nursing process for the patient who
is newly diagnosed with hypertension?
a. providing education on keeping a journal of blood pressure readings
b. setting goals and outcome criteria with the patient’s input
, c. recording a drug history regarding over-the-counter medications used at home
d. formulating human needs statements regarding insufficient knowledge related to the new
treatment regimen
CORRECT ANSWER>>>a
education is an intervention that occurs during the implementation phase. setting goals and outcomes
reflects the planning phase. recording a drug history reflects the assessment phase. formulating human
needs statements reflects analysis of data as part of planning.
dif: cognitive level: applying (application) top: nursing process: implementation
msc: nclex: safe and effective care environment: management of care
6. the medication order reads, “give ondansetron (zofran) 4 mg, 30 minutes before beginning
chemotherapy to prevent nausea.” the nurse notes that the route is missing from the order. what is the
nurse’s best action?
a. give the medication intravenously because the patient might vomit.
b. give the medication orally because the tablets are available in 4-mg doses.
c. contact the prescriber to clarify the route of the medication ordered.
d. hold the medication until the prescriber returns to make rounds.
CORRECT ANSWER>>>c
a complete medication order includes the route of administration. if a medication order does not
include the route, the nurse must ask the prescriber to clarify it. the intravenous and oral routes are not
interchangeable. holding the medication until the prescriber returns would mean that the patient would
not receive a needed medication.
dif: cognitive level: applying (application)
top: nursing process: implementation
msc: nclex: safe and effective care environment: management of care
7. when the nurse considers the timing of a drug dose, which factor is appropriate to consider
when deciding when to give a drug?
a. the patient’s ability to swallow
b. the patient’s height
c. the patient’s last meal
pharmacology and the nursing process 9th
edition by lilley
(covers chapters 1-58 with 100% verified
answer)
,table of contents
chapter 01: the nursing process and drug therapy .............................................. 5
chapter 02: pharmacologic principles .................................................................. 9
chapter 03: lifespan considerations ................................................................... 17
chapter 04: cultural, legal, and ethical considerations ...................................... 24
chapter 05: medication errors: preventing and responding ............................... 30
chapter 06: patient education and drug therapy ............................................... 35
chapter 07: over-the-counter drugs and herbal and dietary supplements ......... 40
chapter 08: gene therapy and pharmacogenomics............................................ 45
chapter 09: photo atlas of drug administration ................................................. 50
chapter 10: analgesic drugs .............................................................................. 61
chapter 11: general and local anesthetics ......................................................... 69
chapter 12: central nervous system depressants and muscle relaxants ............. 73
chapter 13: central nervous system stimulants and related drugs ..................... 79
chapter 14: antiepileptic drugs ......................................................................... 84
chapter 15: antiparkinson drugs ....................................................................... 90
chapter 16: psychotherapeutic drugs ................................................................ 96
chapter 17: substance use disorder ................................................................. 104
chapter 18: adrenergic drugs .......................................................................... 110
chapter 19: adrenergic-blocking drugs ............................................................ 115
chapter 20: cholinergic drugs .......................................................................... 121
chapter 21: cholinergic-blocking drugs ............................................................ 127
chapter 22: antihypertensive drugs ................................................................. 133
chapter 23: antianginal drugs ......................................................................... 141
chapter 24: heart failure drugs........................................................................ 147
chapter 25: antidysrhythmic drugs .................................................................. 154
chapter 26: coagulation modifier drugs .......................................................... 160
chapter 27: antilipemic drugs.......................................................................... 167
,chapter 28: diuretic drugs ............................................................................... 173
chapter 29: fluids and electrolytes .................................................................. 180
chapter 30: pituitary drugs ............................................................................. 187
chapter 31: thyroid and antithyroid drugs....................................................... 191
chapter 32: antidiabetic drugs ........................................................................ 197
chapter 33: adrenal drugs ............................................................................... 207
chapter 34: women’s health drugs .................................................................. 212
chapter 35: men’s health drugs ....................................................................... 221
chapter 36: antihistamines, decongestants, antitussives, and expectorants .... 226
chapter 37: respiratory drugs .......................................................................... 232
chapter 38: antibiotics part 1 .......................................................................... 238
chapter 39: antibiotics part 2 .......................................................................... 246
chapter 40: antiviral drugs .............................................................................. 252
chapter 41: antitubercular drugs..................................................................... 258
chapter 42: antifungal drugs ........................................................................... 264
chapter 43: antimalarial, antiprotozoal, and anthelmintic drugs .................... 270
chapter 44: anti-inflammatory and antigout drugs ......................................... 275
chapter 45: antineoplastic drugs part 1: cancer overview and cell cycle-specific
drugs .............................................................................................................. 282
chapter 46: antineoplastic drugs part 2: cell cycle–nonspecific drugs and
miscellaneous drugs........................................................................................ 288
chapter 47: biologic response–modifying and antirheumatic drugs................. 294
chapter 48: immunosuppressant drugs ........................................................... 300
chapter 49: immunizing drugs ......................................................................... 306
chapter 50: acid-controlling drugs................................................................... 311
chapter 51: bowel disorder drugs .................................................................... 318
chapter 52: antiemetic and antinausea drugs ................................................. 327
chapter 53: vitamins and minerals .................................................................. 333
,chapter 54: anemia drugs ............................................................................... 339
chapter 55: nutritional supplements ............................................................... 347
chapter 56: dermatologic drugs ...................................................................... 353
chapter 57: ophthalmic drugs ......................................................................... 360
chapter 58: otic drugs ..................................................................................... 365
,chapter 01: the nursing process and drug therapy
lilley: pharmacology and the nursing process, 9th edition
multiple choice
1. the nurse is developing a human needs statement for a patient who has a new diagnosis of
heart failure. identification of human needs statements occur with which of these activities?
a. collection of patient data
b. administering interventions
c. deciding on patient outcomes
d. documenting the patient’s behavior
CORRECT ANSWER>>>a
identification of human needs occurs with the collection of patient data.
dif: cognitive level: understanding (comprehension) top: nursing process: human needs statement
msc: nclex: safe and effective care environment: management of care
2. the patient is to receive oral guaifenesin (mucinex) twice a day. today, the nurse was busy and
gave the medication 2 hours after the scheduled dose was due. what type of problem does this
represent?
a. “right time”
b. “right dose”
c. “right route”
d. “right medication”
CORRECT ANSWER>>>a
“right time” is correct because the medication was given more than 30 minutes after the scheduled dose
was due. “dose” is incorrect because the dose is not related to the time the medication administration is
scheduled. “route” is incorrect because the route is not affected. “medication” is incorrect because the
medication ordered will not change.
dif: cognitive level: applying (application) top: nursing process: implementation
msc: nclex: safe and effective care environment: safety and infection control
,3. the nurse has been monitoring the patient’s progress on a new drug regimen since the first dose
and documenting the patient’s therapeutic response to the medication. which phase of the nursing
process do these actions illustrate?
a. human needs statement
b. planning
c. implementation
d. evaluation
CORRECT ANSWER>>>d
monitoring the patient’s progress, including the patient’s response to the medication, is part of the
evaluation phase. planning, implementation, and human needs statement are not illustrated by this
example.
dif: cognitive level: understanding (comprehension) top: nursing process: evaluation
msc: nclex: safe and effective care environment: management of care
4. the nurse is assigned to a patient who is newly diagnosed with type 1 diabetes mellitus. which
statement best illustrates an outcome criterion for this patient?
a. the patient will follow instructions.
b. the patient will not experience complications.
c. the patient will adhere to the new insulin treatment regimen.
d. the patient will demonstrate correct blood glucose testing technique.
CORRECT ANSWER>>>d
“demonstrating correct blood glucose testing technique” is a specific and measurable outcome criterion.
“following instructions” and “not experiencing complications” are not specific criteria. “adhering to new
regimen” would be difficult to measure.
dif: cognitive level: applying (application) top: nursing process: planning
msc: nclex: safe and effective care environment: management of care
5. which activity best reflects the implementation phase of the nursing process for the patient who
is newly diagnosed with hypertension?
a. providing education on keeping a journal of blood pressure readings
b. setting goals and outcome criteria with the patient’s input
, c. recording a drug history regarding over-the-counter medications used at home
d. formulating human needs statements regarding insufficient knowledge related to the new
treatment regimen
CORRECT ANSWER>>>a
education is an intervention that occurs during the implementation phase. setting goals and outcomes
reflects the planning phase. recording a drug history reflects the assessment phase. formulating human
needs statements reflects analysis of data as part of planning.
dif: cognitive level: applying (application) top: nursing process: implementation
msc: nclex: safe and effective care environment: management of care
6. the medication order reads, “give ondansetron (zofran) 4 mg, 30 minutes before beginning
chemotherapy to prevent nausea.” the nurse notes that the route is missing from the order. what is the
nurse’s best action?
a. give the medication intravenously because the patient might vomit.
b. give the medication orally because the tablets are available in 4-mg doses.
c. contact the prescriber to clarify the route of the medication ordered.
d. hold the medication until the prescriber returns to make rounds.
CORRECT ANSWER>>>c
a complete medication order includes the route of administration. if a medication order does not
include the route, the nurse must ask the prescriber to clarify it. the intravenous and oral routes are not
interchangeable. holding the medication until the prescriber returns would mean that the patient would
not receive a needed medication.
dif: cognitive level: applying (application)
top: nursing process: implementation
msc: nclex: safe and effective care environment: management of care
7. when the nurse considers the timing of a drug dose, which factor is appropriate to consider
when deciding when to give a drug?
a. the patient’s ability to swallow
b. the patient’s height
c. the patient’s last meal
